The FUTR podcast spoke with MemVerge CEO Charles Fan: "Sandesh and I first met MemVerge’s founder and CEO, Charles,...
Read moreLinnaeus Therapeutics announced the expansion of its ongoing clinical collaboration with Merck to include multiple additional phase 2 cohorts....
Read moreProvivi® Inc. proudly announces three award wins for its video campaign collaboration with filmmaker Richard Goldgewicht at the 41st...
Read moreBaroness Susan Greenfield is, among other things, a scientist, author, broadcaster, member of the House of Lords and the...
Read moreDEARhealth announced that it has obtained certification for ISO 13485 (quality management systems for medical devices) and the certificate...
Read moreLinnaeus Therapeutics, Inc. announced the presentation of clinical data from its phase 1 dose-escalation study of LNS8801 as a...
Read moreMixComm announced the latest addition to its portfolio of breakthrough front-end ICs for 5G mmWave. The SUMMIT 3741 integrates...
Read moreFoldax announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve....
Read moreThe approval clears the way for Kachlany’s company, Actinobac Biomed, to initiate a phase I clinical trial in patients...
Read moreScientists at Sienza Energy in Pasadena, a Caltech spinoff, are developing two trendsetting batteries for electric vehicles and consumer...
Read more